Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
4,17 USD | +5,84 % | +5,57 % | -83,22 % |
14/05 | RAPT THERAPEUTICS, INC. : Reducido a Neutral por Wolfe Research | ZM |
10/05 | RAPT THERAPEUTICS, INC. : Guggenheim es menos optimista | ZM |
Resumen de negocios
Número de empleados: 126
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Brian Wong
CEO | Chief Executive Officer | 52 | 01/08/15 |
Rodney Young
DFI | Director of Finance/CFO | 61 | 02/12/19 |
Jim Farmer
CTO | Chief Tech/Sci/R&D Officer | - | 04/05/22 |
William Ho
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/05/15 |
Dirk Brockstedt
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/01/18 |
Nipun Davar
CTO | Chief Tech/Sci/R&D Officer | - | 13/02 |
Investor Relations Contact | 63 | - | |
General Counsel | - | 03/05/23 | |
Adnan Rahman
PRN | Corporate Officer/Principal | - | 28/09/22 |
Shari L. Geffon
PRN | Corporate Officer/Principal | - | 04/05/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Mary Gray
BRD | Director/Board Member | 71 | 04/12/19 |
William Rieflin
CHM | Chairman | 64 | 01/05/15 |
Wendye Robbins
BRD | Director/Board Member | 63 | 22/10/19 |
Brian Wong
CEO | Chief Executive Officer | 52 | 01/08/15 |
Michael Giordano
BRD | Director/Board Member | 66 | 01/01/18 |
Linda Kozick
BRD | Director/Board Member | 66 | 01/12/16 |
Director/Board Member | 46 | 09/11/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 34 799 702 | 32 933 918 ( 94,64 %) | 0 | 94,64 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-83,22 % | 138 M | |
+18,72 % | 123 mil M | |
+14,53 % | 107 mil M | |
-2,88 % | 24,01 mil M | |
+2,18 % | 22,59 mil M | |
-10,09 % | 18,16 mil M | |
-41,04 % | 16,84 mil M | |
-11,83 % | 16,23 mil M | |
+1,46 % | 13,43 mil M | |
+24,22 % | 11,32 mil M |
- Bolsa de valores
- Acciones
- Acción RAPT
- Empresa RAPT Therapeutics, Inc.